The Experts below are selected from a list of 25740 Experts worldwide ranked by ideXlab platform
Francisco M. Domenech - One of the best experts on this subject based on the ideXlab platform.
-
Multiple aseptic Bone Necrosis detected by Tc-99m MDP Bone scintigraphy in a patient with systemic lupus erythematosus on corticosteroid therapy.
Clinical Nuclear Medicine, 1998Co-Authors: Montse Minoves, Eduardo Riera, Jose M. Costansa, Setoain J, P. Bassa, Francisco M. DomenechAbstract:Avascular Bone Necrosis is a serious complication in patients with systemic lupus erythematosus (SLE). The femoral heads are the most frequent Necrosis sites. Although its pathogenesis still remains unclear, abnormal hemostatic states and the young age of patients with SLE have previously been proposed as risk factors. It is also well known that corticosteroids are a major osteoNecrosis inducing factor. The authors report the case of a 25-year-old woman who was diagnosed with SLE 4 years earlier, and who had hemolytic anemia. She had been treated with corticosteroids, had bilateral hip pain for 3 months, and pain in the left shoulder and right knee for 1 month.
-
Multiple aseptic Bone Necrosis detected by Tc-99m MDP Bone scintigraphy in a patient with systemic lupus erythematosus on corticosteroid therapy.
Clinical nuclear medicine, 1998Co-Authors: Montse Minoves, Eduardo Riera, Jose M. Costansa, P. Bassa, J Setoain, Francisco M. DomenechAbstract:Avascular Bone Necrosis is a serious complication in patients with systemic lupus erythematosus (SLE). The femoral heads are the most frequent Necrosis sites. Although its pathogenesis still remains unclear, abnormal hemostatic states and the young age of patients with SLE have previously been propo
Montse Minoves - One of the best experts on this subject based on the ideXlab platform.
-
Multiple aseptic Bone Necrosis detected by Tc-99m MDP Bone scintigraphy in a patient with systemic lupus erythematosus on corticosteroid therapy.
Clinical Nuclear Medicine, 1998Co-Authors: Montse Minoves, Eduardo Riera, Jose M. Costansa, Setoain J, P. Bassa, Francisco M. DomenechAbstract:Avascular Bone Necrosis is a serious complication in patients with systemic lupus erythematosus (SLE). The femoral heads are the most frequent Necrosis sites. Although its pathogenesis still remains unclear, abnormal hemostatic states and the young age of patients with SLE have previously been proposed as risk factors. It is also well known that corticosteroids are a major osteoNecrosis inducing factor. The authors report the case of a 25-year-old woman who was diagnosed with SLE 4 years earlier, and who had hemolytic anemia. She had been treated with corticosteroids, had bilateral hip pain for 3 months, and pain in the left shoulder and right knee for 1 month.
-
Multiple aseptic Bone Necrosis detected by Tc-99m MDP Bone scintigraphy in a patient with systemic lupus erythematosus on corticosteroid therapy.
Clinical nuclear medicine, 1998Co-Authors: Montse Minoves, Eduardo Riera, Jose M. Costansa, P. Bassa, J Setoain, Francisco M. DomenechAbstract:Avascular Bone Necrosis is a serious complication in patients with systemic lupus erythematosus (SLE). The femoral heads are the most frequent Necrosis sites. Although its pathogenesis still remains unclear, abnormal hemostatic states and the young age of patients with SLE have previously been propo
Graham Bryce - One of the best experts on this subject based on the ideXlab platform.
-
Temporal Bone Necrosis: Diagnosis, Classification, and Management
Otolaryngology-Head and Neck Surgery, 2000Co-Authors: Irvin Pathak, Graham BryceAbstract:OBJECTIVE: The goal of this study was to analyze temporal Bone Necrosis and classify its diagnosis and treatment according to extent of Necrosis and cause.METHODS AND MATERIAL: Twenty-six cases of temporal Bone Necrosis were retrospectively reviewed between 1988 and 1997 at the University of British Columbia.RESULTS: Patients were classified on the basis of disease extent restricted to the tympanic Bone or extension beyond the tympanic Bone, as well as on the basis of the cause of disease; treatment based on classification. Patients with localized disease of the tympanic Bone had minimal symptoms. Those with radiation-induced localized Necrosis were less likely to respond to conservative medical management. Patients with diffuse disease were more likely to require surgical intervention.CONCLUSIONS: Temporal Bone Necrosis comprises a spectrum of disease from idiopathic tympanic Bone Necrosis, which rarely requires surgery, to the more severe forms of radiation-induced diffuse temporal Bone Necrosis that ma...
Pota Sung - One of the best experts on this subject based on the ideXlab platform.
-
gingival and localized alveolar Bone Necrosis related to the use of arsenic trioxide paste two case reports
Journal of the Formosan Medical Association, 2014Co-Authors: Gin Den Chen, Pota SungAbstract:The leakage of arsenic trioxide paste from tooth fillings has been associated with widespread Necrosis of the supporting periodontal tissues. This report describes two cases of arsenic trioxide paste-induced gingival and localized alveolar Bone Necrosis in the mandible, following the use of arsenic trioxide paste as a pulp-devitalized agent. The first case was a 54-year-old female complaining of a painful white patch on the gingival tissue of the left mandibular second molar (tooth #37) after treatment by a private dentist. She underwent completely debridement of all necrotic soft tissue with physical saline irrigation. The gingival tissue was gradually replaced with vascular tissue and completely healed after 7 weeks. The second case was a 30-year-old female complaining of severe pain and continuous gingival bleeding from the right maxillary first bicuspid (tooth #14) following treatment by a private dentist. She finally accepted debridement of the sequestrum and necrotic alveolar Bone with decortication to induce active bleeding. A partial thickness gingival flap was made to cover the wound. Four weeks later, the supporting tissues had completely healed. Arsenic trioxide paste is a cytotoxic agent and may cause harmful adverse effects on adjacent periodontium and supporting hard tissue if leakage occurs, or it is used carelessly. There is no indication for the use of arsenic trioxide paste in modern dental practice.
-
Gingival and localized alveolar Bone Necrosis related to the use of arsenic trioxide paste—Two case reports
Journal of the Formosan Medical Association, 2012Co-Authors: Gin Den Chen, Pota SungAbstract:The leakage of arsenic trioxide paste from tooth fillings has been associated with widespread Necrosis of the supporting periodontal tissues. This report describes two cases of arsenic trioxide paste-induced gingival and localized alveolar Bone Necrosis in the mandible, following the use of arsenic trioxide paste as a pulp-devitalized agent. The first case was a 54-year-old female complaining of a painful white patch on the gingival tissue of the left mandibular second molar (tooth #37) after treatment by a private dentist. She underwent completely debridement of all necrotic soft tissue with physical saline irrigation. The gingival tissue was gradually replaced with vascular tissue and completely healed after 7 weeks. The second case was a 30-year-old female complaining of severe pain and continuous gingival bleeding from the right maxillary first bicuspid (tooth #14) following treatment by a private dentist. She finally accepted debridement of the sequestrum and necrotic alveolar Bone with decortication to induce active bleeding. A partial thickness gingival flap was made to cover the wound. Four weeks later, the supporting tissues had completely healed. Arsenic trioxide paste is a cytotoxic agent and may cause harmful adverse effects on adjacent periodontium and supporting hard tissue if leakage occurs, or it is used carelessly. There is no indication for the use of arsenic trioxide paste in modern dental practice.
P. Bassa - One of the best experts on this subject based on the ideXlab platform.
-
Multiple aseptic Bone Necrosis detected by Tc-99m MDP Bone scintigraphy in a patient with systemic lupus erythematosus on corticosteroid therapy.
Clinical Nuclear Medicine, 1998Co-Authors: Montse Minoves, Eduardo Riera, Jose M. Costansa, Setoain J, P. Bassa, Francisco M. DomenechAbstract:Avascular Bone Necrosis is a serious complication in patients with systemic lupus erythematosus (SLE). The femoral heads are the most frequent Necrosis sites. Although its pathogenesis still remains unclear, abnormal hemostatic states and the young age of patients with SLE have previously been proposed as risk factors. It is also well known that corticosteroids are a major osteoNecrosis inducing factor. The authors report the case of a 25-year-old woman who was diagnosed with SLE 4 years earlier, and who had hemolytic anemia. She had been treated with corticosteroids, had bilateral hip pain for 3 months, and pain in the left shoulder and right knee for 1 month.
-
Multiple aseptic Bone Necrosis detected by Tc-99m MDP Bone scintigraphy in a patient with systemic lupus erythematosus on corticosteroid therapy.
Clinical nuclear medicine, 1998Co-Authors: Montse Minoves, Eduardo Riera, Jose M. Costansa, P. Bassa, J Setoain, Francisco M. DomenechAbstract:Avascular Bone Necrosis is a serious complication in patients with systemic lupus erythematosus (SLE). The femoral heads are the most frequent Necrosis sites. Although its pathogenesis still remains unclear, abnormal hemostatic states and the young age of patients with SLE have previously been propo